BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 2667784)

  • 21. Comparison of intestinal calcium absorption and circulating 1,25-dihydroxyvitamin D levels in malignancy-associated hypercalcaemia and primary hyperparathyroidism.
    Ralston SH; Cowan RA; Gardner MD; Fraser WD; Marshall E; Boyle IT
    Clin Endocrinol (Oxf); 1987 Mar; 26(3):281-91. PubMed ID: 3652475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations.
    Walls J; Ratcliffe WA; Howell A; Bundred NJ
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):407-13. PubMed ID: 7955450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone resorption and renal calcium reabsorption in renal cell carcinoma-bearing mice: the effects of bisphosphonate.
    Weissglas M; Löwik C; Schamhart D; Theuns H; Kurth KH; Papapoulos S
    BJU Int; 2007 Jun; 99(6):1530-3. PubMed ID: 17428243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy.
    Bundred NJ; Walls J; Ratcliffe WA
    Ann R Coll Surg Engl; 1996 Jul; 78(4):354-8. PubMed ID: 8712650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment.
    Mosekilde L; Eriksen EF; Charles P
    Crit Rev Oncol Hematol; 1991; 11(1):1-27. PubMed ID: 1883526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of cancer-induced hypercalcemia.
    Rosol TJ; Capen CC
    Lab Invest; 1992 Dec; 67(6):680-702. PubMed ID: 1460860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms and treatment of hypercalcemia of malignancy.
    Clines GA
    Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parathyroid hormone related protein and hypercalcaemia in breast cancer.
    Bundred NJ; Ratcliffe WA; Walker RA; Coley S; Morrison JM; Ratcliffe JG
    BMJ; 1991 Dec; 303(6816):1506-9. PubMed ID: 1782489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypercalcaemia in cerebellar medulloblastoma: pathogenesis of solid tumour-associated hypercalcaemia.
    Arisaka O; Obinata K; Yabuta K; Ishimoto K; Sato K
    Eur J Pediatr; 1987 Jul; 146(4):434-6. PubMed ID: 3653140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypercalcaemia and the synthesis of interleukin-1 by an ameloblastoma.
    Macpherson DW; Hopper C; Meghji S
    Br J Oral Maxillofac Surg; 1991 Feb; 29(1):29-33. PubMed ID: 2004073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypercalcaemia. What does it signify?
    Evans RA
    Drugs; 1986 Jan; 31(1):64-74. PubMed ID: 3940849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Malignant humoral hypercalcemia and the parathyroid hormone related protein].
    Jemtland R; Rian E; Gautvik KM
    Tidsskr Nor Laegeforen; 1991 May; 111(14):1738-42. PubMed ID: 2063384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitation of the renal effect of calcitonin in the hypercalcaemia of malignancy.
    Hosking DJ; Heller SR
    Eur J Clin Pharmacol; 1986; 31(1):27-31. PubMed ID: 3780823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of osteolytic bone destruction.
    Mundy GR
    Bone; 1991; 12 Suppl 1():S1-6. PubMed ID: 1954046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disorders of calcium homeostasis.
    Carmeliet G; Van Cromphaut S; Daci E; Maes C; Bouillon R
    Best Pract Res Clin Endocrinol Metab; 2003 Dec; 17(4):529-46. PubMed ID: 14687587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia.
    Ratcliffe WA; Hutchesson AC; Bundred NJ; Ratcliffe JG
    Lancet; 1992 Jan; 339(8786):164-7. PubMed ID: 1346019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.
    Fraser WD; Logue FC; Gallacher SJ; O'Reilly DS; Beastall GH; Ralston SH; Boyle IT
    Bone Miner; 1991 Feb; 12(2):113-21. PubMed ID: 1849762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary hyperparathyroidism in paraneoplastic hypercalcaemia.
    Drezner MK; Lebovitz HE
    Lancet; 1978 May; 1(8072):1004-6. PubMed ID: 76931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of parathyroid hormone-related protein in tumour xenografts in nude mice presenting with hypercalcaemia.
    Miyake Y; Yamaguchi K; Honda S; Nagasaki K; Tsuchihashi T; Mori M; Kimura S; Abe K
    Br J Cancer; 1991 Feb; 63(2):252-6. PubMed ID: 1997102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia.
    Müssig K; Petersenn S; Wehrmann M; Horger M; Vierling P; Häring HU; Gallwitz B
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):719-23. PubMed ID: 17625444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.